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Industrial biotechnologyProteins secreted byGram-positive bacteria are released into the culturemediumwith the obvious beneﬁt that they
usually retain their native conformation. This propertymakes these host cells potentially interesting for the produc-
tion of recombinant proteins, as one can take full proﬁt of establishedprotocols for the puriﬁcationof activeproteins.
Several state-of-the-art strategies to increase the yield of the secreted proteinswill be discussed, using Streptomyces
lividans as an example and compared with approaches used in some other host cells. It will be shown that ap-
proaches such as increasing expression and translation levels, choice of secretion pathway and modulation of pro-
teins thereof, avoiding stress responses by changing expression levels of speciﬁc (stress) proteins, can be helpful to
boost production yield. In addition, the potential of multi-omics approaches as a tool to understand the genetic
background and metabolic ﬂuxes in the host cell and to seek for new targets for strain and protein secretion im-
provement is discussed. It will be shown that S. lividans, along with other Gram-positive host cells, certainly plays
a role as a production host for recombinant proteins in an economically viable way. This article is part of a Special
Issue entitled: Protein trafﬁcking and secretion in bacteria. Guest Editors: Anastassios Economou and Ross Dalbey.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Recombinant proteins have become indispensible for academia and
industry, for innovative research and thedevelopment of novelmedicines
of which many enter preclinical and clinical developments each year. For
the production of recombinant proteins, various hosts have been used
over the years. Reasons to select a speciﬁc host are plentiful including de-
velopment and running cost, yield, and easiness of downstream process-
ing, time to market, necessity of correct glycosylation, and available
infrastructure. Today, current therapeutic and FDA-approved compounds
are produced by only a small set of host cells including Escherichia coli,
Chinese hamster ovary (CHO) cells, Saccharomyces cerevisiae and Pichia
pastoris [1], but to produce any kind of heterologous protein the by far
most commonly used host remains E. coli for obvious reasons. Notwith-
standing its general use, and besides the fact that not all proteins can be
equally well expressed in E. coli, this host has a number of possible
drawbacks. As a Gram-negative bacterium, E. coli is enveloped with an
outer membrane containing lipopolysaccharides, a source of endo-
toxins. The outer membrane also hinders the secretion of proteins





ights reserved.the expressed proteins in the periplasm as inclusion bodies. In these in-
soluble aggregates proteins are in an inactive conformation and it is
often difﬁcult to recover them in an active form. Protein secretion into
the culture medium can thus be advantageous. While the cytoplasm is
a reducing environment which hinders the formation of disulﬁde
bonds, the oxidizing environment of the extracellular medium favours
disulﬁde bond formation, and hence, correct folding is more likely. Fur-
thermore, extracellular secretion facilitates downstreamprocessing and
gives the possibility for continuous culturing. As a consequence, many
attempts have been made for E. coli to target recombinant proteins to
the culture medium [2–7]. However, such modiﬁed E. coli systems
have not been widely used at an industrial scale.
Since Gram-positive bacteria such as Streptomyces lividans do not
have an outer membrane, secreted proteins are directly released into
the culture medium, and therefore, are considered potentially interest-
ing hosts. Streptomycetes, soil-dwelling bacteria belonging to the
phylum Actinobacteria, have a GC-rich (70–73% GC) genome with a re-
markably large size of up to 11.04 Mbps and with gene clusters from
just a few to more than 30 pathways for the biosynthesis of a diverse
range of secondary metabolites [8]. Streptomycetes play an important
role in nature as they decompose decaying vegetation, and as such are
important in the C and N cycle. Typical for streptomycetes is their com-
plex life cycle: under suitable growth conditions exospores germinate
and subsequently develop into hyphae, which frequently become
branched forming the vegetative mycelia that subsequently differenti-
ate to aerial mycelia. Finally, aerial mycelia become divided into long
chains of prespore compartments, which eventually mature to thick-
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ary metabolites is produced [9]. Many of these secondary metabolites
are of industrial and pharmaceutical value, including antibiotics for
human and veterinary medicine or applied in agriculture, anticancer
and immunosuppressive agents, other pharmacologically-active com-
pounds, anti-parasitic agents, and herbicides.
Because streptomycetes have to survive the harsh and hostile en-
vironment of the soil with many competitors, they have devel-
oped this unique metabolic diversity, but also important enzymatic
capability needed to exploit complex organicmaterial in the soil for nu-
trient acquisition. As a consequence, these soil bacteria secrete a large
variety of hydrolytic enzymes. For example, the model Streptomyces
sp., Streptomyces coelicolor, encodes 819 potentially secreted proteins
including hydrolases, proteases/peptidases, chitinases/chitosanases,
cellulases/endoglucanases, amylases and pectate lyases [10]. Several
of the enzymes produced by streptomycetes are economically valuable,
e.g., glucose isomerases produced by Streptomyces olivaceus, Streptomyces
olivochromogenes, Streptomyces rubigenosus and Streptomyces murinus
are used for high fructose syrup production, and Streptomyces
mobaraensis transglutaminase is applied for quality improvement
of processed meat and ﬁsh products, and for textural improvement of
noodles. In the context of bio-sustainable energy production, streptomy-
cetes isolates are also interesting because of their cellulolytic ability and
the production of xylanases. For example, S. lividans [11], Streptomyces
viridosporus [12] and Streptomyces thermoviolaceus [13] produce
xylanase. Secreted extracellular enzymes can be used e.g., for indus-
trial degradation of lignocellulose for bioethanol production and in
the feed industry.
Although S. coelicolor is themodel organism for genetic andmorpho-
logical analysis, for cloning purposes S. lividans, a close relative of the
model organism, is the host of choice. Reasons therefore are that its re-
striction system is insensitive to methylated DNA and that the species
has only low endogenous protease activity making it an attractive host
for expression of heterologous proteins and biosynthetic pathways of in-
terest both for academic as well as for industrial purposes. Very recently,
the genome sequence of S. lividans 1326 has been published [14] and a
draft genome of S. lividans TK24 became available (to be published).
This leads to new opportunities to get better insight in the protein se-
cretion process, and the stress and metabolic burden it can cause, and,
hence, to more rational strain optimization.Fig. 1. Routes for improvement of heIn this review, the potentiality and applications of some Gram-
positive bacteria with particular emphasis on S. lividans as a host for
the secretory production of heterologous proteins will be discussed
and possible bottlenecks in protein secretion and state-of-the art strat-
egies for improvement are provided (Fig. 1).
2. Protein secretion pathways in Streptomyces spp.
Various streptomycetes efﬁciently secrete native proteins in high
amounts, a property which can be exploited for the production of
heterologous proteins. Both the Sec-dependent and the twin-arginine
translocation (Tat) pathway have shown to be useful in this respect.
Furthermore, in streptomycetes, as in other actinobacteria the ESX-1
pathway is present.
Proteins targeted to the Sec- or Tat-dependent pathway are synthe-
sized as preproteins with an N-terminal hydrophobic signal peptide
(SP) with a positively charged N-domain followed by a longer, hydro-
phobic H-domain and a C-terminal part containing at the end three
amino acids which together with a limited part of the mature protein
form the signal peptidase recognition site [15]. Proteins secreted via
the ESX-1 pathway lack a classical signal peptide, but possess a seven
amino acid secretion signal at the C-terminus [16].
The average length of a signal peptide of Sec-dependent preproteins
is 35 amino acids for streptomycetes [17], while signal peptides of other
Gram-positive bacteria consist of 29–31 amino acids. The additional
amino acids of Streptomyces spp. are located in the N-terminal region
of the SP, and are often positively charged. To predict signal peptides
of proteins from the amino acid sequence, many in silico methods
have been published [18]. Signal peptides that target proteins to the
Tat pathway resemble Sec signal peptides but with a conserved S/T-R-
R-x-F-L-K consensus motif [19]. It has been shown, however, that the
Tat-speciﬁc signal sequence with two arginine residues is not always
an absolute prerequisite for the Tat pathway [20]. Several computation-
al prediction programmes to detect putative Tat substrates in bacterial
genomes are available e.g., TATFIND [21], TatP [22] and PRED-TAT, the
latter which is a novel method for predicting and discriminating Sec
from Tat signal peptides [23].
During or after translocation, the SP is cleaved off by a type I signal
peptidase (SPase I) and the mature protein is then released into the
culture supernatant. Streptomycetes possess four SPases I (SipX,terologous protein production.
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ities [24]. None of the corresponding genes seems to be essential
for secretion. SipY was shown to be the most important SPase I for
protein secretion [25].
The following paragraphs brieﬂy summarize the structure and func-
tion of the protein secretion pathways in Streptomyces. For a more de-
tailed overview on the secretion pathways in bacteria, the interested
reader is referred to other chapters in this issue.
2.1. Sec-dependent protein secretion pathway
The major protein secretion route in streptomycetes is the Sec-
dependent pathway, which as in other bacteria consists of a number
of proteins including the Sec translocon SecY, SecE, SecG and YajC;
also the protein-export membrane proteins SecF and SecD and inner
membrane protein translocase component YidC are identiﬁed in the
genome of S. lividans [14]. Sec-preproteins are kept unfolded in the cy-
toplasm, a prerequisite to cross the Sec translocon. They achieve their
native conformation following translocation across the membrane.
The energy for the translocation of proteins via this pathway is provided
by the binding energy of ATP following docking of the preprotein on
SecA bound to SecYEG and by the proton-motive force (PMF) [26].
Streptomyces spp. also have the cotranslational secretion system,
the signal recognition particle (SRP) pathway including a ribonucleo-
protein composed of Ffh (ﬁfty four homolog), a short RNA and the SRP
receptor FtsY. FtsY facilitates the cotranslational protein targeting by
recruiting the nascent precursor protein, SRP and the ribosome to
SecYEG. For S. lividans the involvement of SRP in targeting secretory pro-
teins has been experimentally shown [27]. Besides its role in protein
transportation, data showed that S. coelicolor FtsY is necessary for nor-
mal production of actinorhodin and sporulation; and its N-terminus
was indispensable for this function [28].
2.2. Tat-dependent protein secretion pathway
Streptomycetes also contain a functional Tat pathway [29–31]. It has
been experimentally proven that the Tat machinery exports fully folded
proteins across the cytoplasmicmembrane such as tyrosinase, a copper-
containing dioxygen-activating enzyme. The energy for translocation is
provided by the PMF. It has been shown that co-operation exists
between the Sec and Tat systems in the assembly of e.g., the Rieske pro-
tein, an integral membrane protein [32]. Similarly to Gram-negative
bacteria, but opposed to most Gram-positive bacteria in which case
only TatA and TatC are identiﬁed [33], in actinomycetes including
S. lividans and other streptomycetes, and Mycobacterium [34], TatA,
TatB and TatC are the essential components for this pathway. TatA and
TatB are sequence-related proteins with a common structure: each is
predicted to comprise a membrane-spanning α-helix at the amino-
terminus, immediately followed by an amphipathic helix located at
the cytoplasmic side of the membrane and a C-terminal region of vari-
able length. The TatC protein is highly hydrophobic and is predicted to
have 6 transmembrane helices, with the N- and C-termini at the cyto-
plasmic face of the membrane [35]. Whereas for most bacteria with an
identiﬁed Tat pathway, only few proteins are transported via this path-
way, for Streptomyces species the Tat substrate prediction programs
(TATFIND 1.4 and TatP) indicated an exceptionally high number of Tat
substrates: 145 of the 7825 ORFs of S. coelicolor, reduced to 129 using
TATscan [36], of which 25 have been experimentally proven [29]; and
for S. avermitilis using TATFIND1.4, 145 of the 7576ORFswere predicted
to be Tat substrates [21]. Using an agarase reporter assay, it was shown
that the signal peptides of 47 candidate S. scabies Tat substrates were
able to mediate Tat-dependent export, of which 2 were not identiﬁed
by TATFIND 1.4 due to the presence of His, Ile or Phe at P + 1 position
of the twin-arginine sequence motif (R1;R2) [30]. Based on these data,
one assumes that there are more than 100 Tat substrates in S. scabies.
Although the Tat pathway is used in streptomycetes for the secretionof a relatively large number of proteins, the latter pathway is not essen-
tial (in contrast to the Sec-dependent pathway). Elimination of the Tat
pathway resulted in pleomorphic effects including impaired morpho-
logical differentiation, retarded sporulation, and increased permeability
of the cell envelope [30,31]. Studies using ﬂuorescent protein fusions
also showed that the Tat components are highly dynamic and that
they frequently associate with the tips of the vegetative mycelium
[37], suggesting that one of the major sites of protein secretion by the
Tat pathway is at or near the hyphal tips.
2.3. ESX-1 secretion system
The ESX or type VII secretion system (T7SS) is a complex systemwith
many components and substrates, at least in mycobacteria. The best-
studied T7S system is ESX-1, which was ﬁrst detected inMycobacterium
tuberculosis [38], in the non-pathogenic speciesMycobacterium smegmatis
[39] and later also in the ﬁsh pathogen Mycobacterium marinum [40].
M. tuberculosis contains a total of ﬁve ESX systemswhich show similarity
in gene content and gene order. In pathogenicmycobacteria, ESX-1medi-
ates the secretion of virulence factors such as the 6 kDa early secreted an-
tigen target (ESAT-6, EsxA) and the associated 10 kDa culture ﬁltrate
protein (CFP-10, EsxB). Esx proteins are characterized by their small
size (~100 residues) and a WXG motif in the centre of the protein that
forms a hairpin bend [41]. PE/PPE (with a conserved signaturemotif pro-
line–glutamate and proline–proline–glutamate residues near the start of
their encoded proteins) are also secreted by the T7SS. ESX-1 and ESX-5
have been implicated to play major roles in the secretion of PE/PPE pro-
teins [40].
A PSI-BLAST search on sequences retrieved from the NCBI or the
ViruloGenome databases further evidenced the presence of ESAT-6 ho-
mologues in a number of low GC Gram-positive bacteria, and also in
several actinobacteria other thanMycobacterium [41], including all se-
quenced Streptomyces genomes such as S. coelicolor, S. lividans and
S. scabies. The biological importance of this pathway for streptomycetes
is, so far, less well-known, and begins only just to be revealed. For
S. scabies no role in virulence for any of the T7SS components in any of
the plant infection models tested could be detected, but it was demon-
strated that components encoded by the T7SS gene cluster are required
for the normal growth and development of S. scabies [42]. Bymutagenesis
analysis it was shown that also proteins encoded by the esxBA operon and
belonging to the WXG-100 superfamily play a role in morphogenesis in
S. coelicolor [43].
3. Means to improve secretion yield of heterologous proteins
S. lividans has been tested as host organism for a wide variety of
proteins, encoded by genes derived from eukaryotic and prokaryotic
organisms as well as from archaea. Several proteins were produced
at high level and yielded more than 500 mg/l in their native confor-
mation, while others were only secreted at trace amount levels [44].
In some cases, proteins which could hardly or not be produced in
B. subtilis or E. coli such as e.g., xyloglucanase from Jonesia sp. [45]
and CelA from Rhodothermus marinus [46] were successfully pro-
duced with S. lividans. Reasons for differences in yield are not clear,
but they probably occur at the different stages of thewhole production
process, from transcription over translation up to secretion and folding.
Even when yield is already satisfactory, there is still room for improve-
ments on transcriptional and (post-)translational level as well as at the
level of secretion.
Systematic studies pinpointing the stages at which bottlenecks in
protein synthesis and secretion occur are rare. Notwithstanding, several
individual approaches were identiﬁed to successfully improve heterolo-
gous protein production. Examples are codon optimization, the use of
strong and controllable promoters, and the use of stable high-copy plas-
mids. Other ways to maximize secretion are the choice of the secretion
pathway, adaptation of components of the protein secretion pathway,
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gous protein production, and the optimization of transcription/transla-
tion of the heterologous gene(s) and gene product(s).
3.1. Codon usage bias
The high GC content of streptomycetes could be considered an ad-
vantage or disadvantage, dependingon the origin of the geneof interest.
Bacteria and mammals preferentially use different codons. This might
be one of the reasons why so many mammalian genes are poorly
expressed in bacteria. Therefore, codon optimization achieved by re-
placing existing codons of a species with a set of more suitable host co-
dons can be helpful to achieve optimum expression of a foreign gene in
a host cell system. Numerous software applications exist to deal with
synthetic gene design [47]. Alternatively, heterologous expression can
be improved by supplying the host with extra copies of rare tRNA
genes [48]. In streptomycetes, foreign codon DNA sequences (CDSs)
with a lower GC content could nevertheless also be efﬁciently
expressed, and could therefore not account for failure in certain
cases. This was further conﬁrmed by the fact that adaptation of the
heterologous gene to the host codon usage does not necessarily lead
to improved production [49], although sometimes it was beneﬁcial
[50]. Currently, gene mining based on the construction and screening
of complex libraries derived from the metagenome is an important
approach to ﬁnd new enzymes or enzymes with new properties. As
in metagenomics codon optimization is not possible, and as only 40%
of the enzymatic activities may be detected by random cloning in
E. coli, additional hosts including Streptomyces spp. have been suc-
cessfully employed to expand the range of detectable activities in
metagenomic screens [51]. This may be of particular interest for en-
vironmental samples as it has been suggested that the GC content of
complexmicrobial communities seems to be globally and actively in-
ﬂuenced by the environment [52].
3.2. Promoters and host–vector systems
A wide variety of Streptomyces host–vector systems have been de-
veloped, many of which are based on plasmid pIJ101, such as pIJ702
and pIJ486 [53]. As a rule, antibiotic resistance genes are used as selec-
tion marker, but very recently an interesting expression plasmid in
which an S. lividans toxin–antitoxin system (YefM/YoeBsl) was devel-
oped tomaintain high-copyplasmids [54]without theneedof antibiotic
selection. A number of promoters are listed below. Constitutive strong
promoters are for example the vsi promoter from Streptomyces
venezuelae CBS762.70 [55], ermE-up of Streptomyces erythraeus [56],
metalloendopeptidase promoter from Streptomyces cinnamoneus
TH-2 [57], act1 of S. coelicolor CH999 [58], xysA promoter from
S. halstedii [59], the strong kasOp* promoter, engineered from kasO
(also named cpkO or SCO6280) of S. coelicolor, known as an SARP family
regulator and an activator of a cryptic type I polyketide synthase gene
cluster responsible for coelimycin P1 production in S. coelicolor A3 [60].
Inducible promoters are also available such as PnitA from the gene of
Rhodococcus rhodochrous J1 nitrilase [61], or Pace of M. smegmatis
acetamidase [62] and the thiostrepton-inducible PtipA promoter of
S. lividans [63].
3.3. Sec or Tat secretion
Results suggest (see recent review [44], for more details) that
heterologous protein secretion by S. lividans is in general more success-
ful, if the proteins have a prokaryotic origin thanwhen derived from eu-
karyotes. In most instances, the Sec-dependent pathway has been used,
but sometimes the Tat-dependent pathwaywas required such as for the
secretion of eGFP [64]. A comparison between the efﬁciency of both
pathways showed that if the Sec pathway could be used, when the
Sec-dependent signal peptide was replaced by a Tat-dependent signalpeptide, results were in general pitifully low [65,66]. Reasons for yield
differences for distinct heterologous proteins, expressed under the
same conditions, are so far unknown, making predictions about yield
impossible. No rules are available to conclude which pathway is prefer-
ential for efﬁcient secretion, and the trial and error approach is the only
option. When more proteins will have been tested and compared for
secretion via both pathways predictionsmight becomemore likely. Cer-
tainly, besides the (heterologous) protein itself the yield can be inﬂu-
enced by several determinants of the secretion pathway including the
signal peptide, signal peptidases and SecA.
3.4. Importance of signal peptides
From numerous studies on the impact of the nature of the signal
peptide, it became evident that the feature of the signal peptide can
be an important determinant for the secretion efﬁciency of the desired
heterologous protein. To investigate the importance of the signal pep-
tide in protein secretion, several approaches have been followed for
several bacteria: simple exchange of the signal peptide [67], screening
of signal peptide libraries of secreted proteins [68,69], site-speciﬁc mu-
tations with charge variation in the N-region of the signal peptide [70],
saturationmutagenesis of the signal peptide N-domain [71], and direct-
ed evolution [72]. As a conclusion from all these experiments, it is clear
that at the present time, it is still not possible to predict the effect of cer-
tain amino acid exchanges in a speciﬁc SP in combination with a select-
ed target protein. One should also take into consideration that by
changing the amino acid sequence in the signal peptide, the stability of
themRNA can be changed as well as its folding and secondary structure,
which can affect not only secretion, but also expression and translation
levels. Hence, it can be said that a rational modiﬁcation of a fusion of a
SP to a secretion target will still remain a tedious and time-consuming
trial and error process.
3.5. Overexpression signal peptidases
Type I SPases play a pivotal role in protein secretion, and hence,
will most likely also be a determinant factor in the secretion efﬁcien-
cy of heterologous proteins. Many studies have been carried out re-
garding type I SPase speciﬁcity, primarily for E. coli, but also for
B. subtilis, S. lividans and other bacteria (for review, see [73]). How-
ever, our understanding of the preprotein–SPase interaction, sub-
strate preference of different signal peptidases and subsequent
cleavage remains still scarce. Questions like what are the steps
linking preprotein utilization of the Sec and Tat pathways to cleavage
of the signal peptide from the preprotein, remain unanswered. Dif-
ferent approaches have been applied to investigate the substrate
speciﬁcity of type I SPases from Gram-positive bacteria [74]. (1) De-
termination of the in vivo processing efﬁciency of speciﬁc substrates
by individual SPases, and (2) secretome analysis of speciﬁc SPase
knock-out strains, both for B. subtilis and S. lividans. These experiments
clearly demonstrated differences in substrate speciﬁcity for different
signal peptidases. (3) In vitro preprotein binding/processing and pro-
tein secretion in single SPase mutants. Using a biosensor containing
immobilized SPases to investigate SPase speciﬁcity at the binding
level, no preferential binding of a particular preprotein to one or more
SPases was shown for S. lividans SPases. In addition, no speciﬁcity in
in vitro preprotein processing was observed. However, when the in-
volvement of each SPase in the processing of the same preproteins
was investigated by monitoring the accumulation of these proteins in
the culture medium of S. lividans wild type and single SPase deletion
mutants, high-level secretion of several proteins was clearly dependent
upon one speciﬁc SPase or another. Furthermore, results also showed
that none of the S. lividans SPases is speciﬁcally dedicated to the pro-
cessing of Sec- or Tat-dependent precursors and consequently these
SPases act in a secretion pathway independent manner. These results
strongly suggest that there are additional factors other than the
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ence of SPases in vivo [75].
To prevent or reduce possible hindrance of secretory heterologous
preproteins at the secretion machinery (e.g., [76–79]), overexpression
of SPases is an option as illustrated with a few examples. Co-
expression of the 4 sip genes, sipWXYZ, under the control of the induced
tipA promoter resulted in a signiﬁcantly higher amount of extracellular
human CC16 [80]. Most likely, the higher amount of human CC16 in the
supernatant of S. lividans overexpressing SipWXYZ could primarily
be attributed to the activity of SipW, and to a lesser extent to the activity
of SipXYZ. This could be concluded from comparison of the produc-
tion yield, when the different SPases (SipW,X,Y,Z) were individually
overexpressed, since SipX,Y,Z did not have a signiﬁcant effect on
human CC16 secretion. These results also showed supposed substrate
speciﬁcity for the different SPases. Not only for S. lividans but also for
other Gram-positive host cells the favourable inﬂuence of overexpres-
sion of SPase(s) on yield has been shown. Co-expression of the single
signal peptidase SipM and the (1,3-1,4)-β-glucanase of Paenibacillus
macerans in Bacillus megaterium resulted in an increase of glucanase ac-
tivity of approximately 40%, compared to clones lacking the plasmid-
based sipM overexpression [81]. Signal peptidase overexpression
increased the release of mature β-lactamase in E. coli [82] and the pro-
cessing of antibody single-chain fragments in insect cells [83], when
coexpressing the B. subtilis signal peptidase (SipS) with a single chain
antibody fragment (scFv). Such results again demonstrate that low
signal peptidase activity can limit the production of recombinant
proteins.
3.6. Modulation of SecA and its expression
In Sec-dependent protein secretion, the level of SecA whose ac-
tivity is stimulated by high-afﬁnity interactions with preproteins,
plays a pivotal role and the Sec translocon capacity is considered a
major bottleneck. Heterologous preproteins, when highly expressed,
can lead to saturation of the Sec translocon, which may hamper their
secretion and interfere with the export of homologous proteins eventu-
ally leading to cell death [84]. In this context, Schlegel et al. [85] showed
for E. coli that by harmonizing expression levels of the gene encoding
the heterologous Sec-dependent secretory protein with the Sec-
translocon capacity could alleviate this bottleneck and that optimal
yield can only be achieved within a narrowwindow of gene expression
levels.
It was further investigated to what extent SecA modulation could
help to improve protein secretion. Although such investigations
have not been carried out for streptomycetes, the results obtained
for B. subtilis show its potential applicability in the framework of
strain optimization for Streptomyces and other bacteria. Differential
expression levels of SecA in B. subtilis impacted on the secretion
yield of levansucrase and alpha-amylase and showed that various
precursors may exhibit major differences in their dependency for se-
cretion on the amount of functional SecA in the cell [86]. Further-
more, compared to the wild-type SecA, deletion of the 61 amino acids
at the C-terminal region of B. subtilis SecA (bsSecA) led to an 83%
increase in extracellular alkaliphilic Bacillus sp. thermostable alkaline
cellulase, and a 2.2-fold productivity increase of human interferon α
(hIFN-α2b) [87]. It was further shown that the replacement of the C-
termina1 32 amino acids of bsSecA by the corresponding part of the
E. coli SecA (ecSecA) and coexpression of ecSecB together with the
obtained bsSecA hybrid improved the secretion of heterologous model
proteins in B. subtilis [88]. Altogether, these results clearly show that
expression modulation of SecA or deletion of the C-terminal domain
of SecA can enhance the secretion of different heterologous proteins.
It is certainly of further interest to investigate if a promiscuous SecA
can be developed, which will help to improve heterologous protein
secretion yield without affecting the ﬁtness of the cell. Besides mod-
ulation of SecA, also an increase of the amount of SecYEG by co-overexpressing the encoding genes could result in a substantial increase
in protein secretion as shown for B. subtilis using α-amylase as a model
protein [89].
3.7. Overexpression of Tat translocon
Protein yields for Tat-exported proteins are in general substantially
lower than those obtained via Sec export, which is an important barrier
to using the Tat pathway for protein production. The efﬁciency of the
export of the expressed preproteins is in vivo well below 100%. As a
result, upon subcellular fractionation, a substantial fraction of the
preprotein is retained in the cytoplasm [90,91]. This may be due to the
fact that the exportmachinery becomes saturated by overexpressed tar-
get proteins, which occurs for even native Tat export proteins [92]. The
saturation of the export machinery can partially be relieved by co-
expression of proteins of the Tat translocon. The stoichiometry of the
TatABC components seems, however, critical for export function. For ex-
ample, in E. coli overexpression of tatB resulted in complete loss of Tat
transport, overexpression of tatA has a less severe but nonetheless sig-
niﬁcant effect on translocation [93], while high expression of tatC can
relieve saturation of the Tat pathway [91]. Therefore, most attempts to
relieve the saturation problem of the Tat translocon have been done
by the coordinated overexpression of TatABC. This can certainly have a
positive effect on the secretion of Tat-dependent proteins as illustrated
for S. lividans. When TatABC were overproduced, a ﬁvefold increased
xylanase C secretion was noticed. Surprisingly, the overproduction of
TatABC in S. lividans caused a strong reduction in the secretion of the
monitored Sec-dependent substrates [94], suggesting a possible cross-
talk between the Tat- and Sec-dependent protein secretion pathway.
This assumed interaction, however, needs to be further investigated.
Also for the rod-shaped actinomycete Corynebacterium glutamicum
overexpression of Tat components dramatically increased the secretion
of Chryseobacterium proteolyticum pro-protein glutaminase (pro-PG)
and Streptomyces mobaraensis pro-transglutaminase (pro-TG). The
amounts of secreted pro-PG were more than threefold higher when
TatC or TatAC was overexpressed, and there was a further threefold in-
crease when TatABC were overexpressed [95].
3.8. The importance of phage shock protein (Psp) in Tat-dependent secretion
In E. coli the phage-shock-protein (Psp) response is supposed to play
a role in PMF maintenance (reviewed in [96,97]). The regulon consists
of the psp operon (with the pspA, pspB, pspC, pspD and pspE genes),
and the pspF and pspG genes. It is transiently activated by several
forms of extracytoplasmic stress that compromise the energy status of
the cell. These include, but are not limited to, ﬁlamentous phage infec-
tion, high osmolarity, elevated ethanol concentrations, alkaline shock,
and the presence of proton ionophores such as carbonylcyanide m-
chlorophenylhydrazone (CCCP). Dissipation of the PMF has been pro-
posed as a unifying consequence of all these conditions, although this
has not been tested in most cases. Furthermore, pspA is induced under
conditions that block or reduce the efﬁciency of the protein export ma-
chinery. Mutations in E. coli secA, secD and secF, or in components of the
Tat pathway lead to pspA induction [91,98]. The recent ﬁnding that TatA
interacts with PspA does suggest that the physiological role of PspA re-
cruitment to TatAmay control membrane stress at the active translocon
[99]. This could also explain why overexpression of PspA has a positive
inﬂuence on Tat-dependent secretion. PspA overexpression alone
was sufﬁcient to increase almost threefold Tat-dependent secretion of
the native SufI and CueO substrates and the recombinant ssTorA-GFP
protein in E. coli [91]. PspA homologues have also been identiﬁed in
Gram-positive bacteria including in S. lividans (DBSOURCE accession
FJ573214.1) [64], archaea and eukaryotes [100,101]. So far it was
thought that homologues of the PspA protein in bacteria that did not
have the complete psp system in their chromosome, such as S. lividans,
were unlikely to be part of a real Psp response [96]. The effect of PspA
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was investigated both on the physiology and protein secretion. The
PspA-overexpressing strain looked and behaved as the wild type on
all media tested: it showed a similar growth curve as the wild-type
strain in the media used. A comparison of the total amount of secret-
ed homologous proteins after 24 h fermentation showed a 32% in-
crease (±27.6 μg of protein/mg dry weight versus ±36.1 μg of
protein/mg dry weight) for the PspA-overexpressing strain. The ef-
fect of PspA overexpression on the yield of Tat-dependent secretion
in S. lividans was also investigated by comparing the homologous
XlnC and the heterologous eGFP, the latter preceded by the XlnC sig-
nal peptide. In these cases, an almost 4-fold increase in xylanase ac-
tivity was noticed, while the yield of eGFP increased from 6.9 mg/l to
20 mg/l after 48 h of fermentation. Moreover PspA overexpression
has also a positive effect on Sec-dependent protein secretion as ob-
served for E. coli in which hyperexpression of a secretory exoglucanase
of Cellulomonas ﬁmi resulted in saturation of the SecYEG pathway with
subsequent cell death. Following overexpression of PspA in E. coli,
exoglucanase yield could be increasedmore than 80% and the cells sur-
vived [102]. Also for S. lividans, PspA overexpression has a positive effect
on the yield of proteins secreted via the Sec pathway, although less
pronounced, as illustrated for the highly-secreted subtilisin inhibitor
[103]. Surprisingly, Tat-dependent protein secretion is not impaired
in an S. lividansmutantwith inactivated pspA gene as similar yields of
xylanaseC and eGFP were obtained as compared to the yields of the
wild type. These results indicate that Tat-dependent protein secre-
tion as such does not rely on the presence of a functional PspA pro-
tein [103], and that PspA is not an absolute requirement for Tat
secretion and that other factors contributing to the regulation of
the PMF might be able to compensate for the lack of PspA in the
mutant strain, when there is overexpression of a Tat substrate.
Kleerebezem et al. [104] have already shown that in E. coli, the mem-
brane potential in a pspA mutant and in the wild type are approxi-
mately the same. Furthermore, it was shown that pspA is not
induced by overexpression of the Tat substrates SufI or by overex-
pressing Tat substrates that were previously shown to be misfolded
[91]. An increase in PspA synthesis was only caused by mutations
that abolished export nearly completely. To what extent the coordi-
nate expression of other genes can compensate for the absence of
PspA could be looked for via an -omics approach.4. Opportunities for strain improvement with systems biology
One of the most important goals of post-genomic biology is to
elucidate the fundamental logic and constraints that determine the
systematic behaviour of the bacterial cell and its performance
under different (stress) conditions. Nowadays this systematic be-
haviour can be investigated using several advanced and extremely
powerful techniques including i.a. DNA micro-array analysis, multi-
dimensional protein identiﬁcation technology, mass spectrometry-
based techniques for high-throughput proteomics and metabolo-
mics, metabolic ﬂux analysis, and bioinformatics allowing to gain
detailed insight into the function of gene products and to decipher
transcriptional and metabolic networks under different conditions.
Systems biology integrates these experimental and computational
techniques enabling a systematic and fundamental investigation
of the relation between metabolic ﬂuxes, regulatory interactions
and recombinant protein production. The basic understanding of
the mechanisms underlying protein production and the effects it
has on the ﬁtness of the cell will allow engineering the host cell
such that increased yields can be obtained. Data analysis and mathe-
matical frameworks are developed to systematically seek for gene tar-
gets leading to production yield and ﬂux increments (e.g., [105,106]).
Nevertheless, only few works on heterologous protein production
have yet taken the step to metabolic engineering.4.1. Transcriptomics
Transcriptomics, comparing gene expression proﬁles of wild
type, strains showing heterologous protein secretion and strains
with improved production levels may result in valuable information
to understand the gene expression pattern. This information will allow
proposing a suitable way to improve the yield of aimed recombinant
proteins. Because of its improved Tat-dependent protein secretion
(see Section 3.8), the transcriptional proﬁle of the S. lividans pspAmu-
tant was comparedwith thewild-type strain to see if genes were differ-
entially expressed in the pspA mutant (Anné and co-workers, to be
published). A number of geneswere shown to be up- or downregulated
in the mutant strain. Overall, using this micro-array screen containing
all genes of S. lividans, 67 genes were twofold or more upregulated in
the pspAmutant, while 117 genes were downregulated. For the major-
ity of these genes only limited information is available, and many
are annotated as hypothetical or putative proteins. Among the proteins
for which a function is known or predicted, there are several which are
linked to stress regulation (cold shock proteins, sigma factors), while
others are involved in metabolic processes such as energy production
and conversion and general metabolism. Among others, an increased
expression of sco6996 in the pspA mutant was identiﬁed. The corre-
sponding protein SCO6996 shows some homology to the RNA polymer-
ase sigma factor RpoE and experiments in Salmonella Typhimurium
previously showed that RpoE can (at least partially) compensate for
the lack of PspA [107,108]. Loss of either pspA or rpoE leads to a depolar-
ization of the membrane potential, indicating that both can affect the
PMF. Moreover, PspA overproduction could partially compensate for
the loss of RpoE in a Salmonella Typhimurium ΔrpoE strain. Further-
more, Gordon et al. [109] recently showed that overexpression of one
particular sigma factor (SigU) in S. coelicolor could lead to a signiﬁcant
alteration in the secretome. The SigU-overproducing strain secreted a
much greater quantity and diversity of proteins than the wild-type
strain, revealing that modiﬁcation of the sigma factor expression in
S. lividans might also affect protein secretion. Overexpression of
sco6996 led to an increased secretion of the tested proteins (XylC,
eGFP) through the Tat pathway. This increase was far less pronounced
than in the case of pspA overexpression, but still yielded a 20% increase
in ﬁnal protein yield, which is still highly interesting.
In another study, transcriptomics expression proﬁles of S. lividans
TK24 strains producing the heterologous proteins human/mouse
tumour necrosis factor alpha (hTNFα/mTNFα), monomeric red ﬂuores-
cent protein, and xyloglucanase were compared to the corresponding
control strain containing the empty vector only. Based on these analy-
ses, a number of genes showed a signiﬁcant 2-fold change in the recom-
binant strains overproducing the heterologous proteins. One gene,
encoding a phosphoenolpyruvate carboxykinase (PEP carboxykinase)
involved in the tricarboxylic acid (TCA) cycle and gluconeogenesis,
was selected for further investigation. Overexpression of this gene in
S. lividans TK24 hTNFα and xyloglucanase C production strains in-
creased almost 2-fold the yield of recombinant hTNFα [110] and Xyl C
in comparison with the initial production strains. Overall, these results
show that a transcriptomics-based approach represents a useful
tool for a rational optimization of heterologous protein secretion in
S. lividans.
4.2. Metabolomics and ﬂuxomics
It is generally acknowledged that heterologous protein expression ex-
erts a metabolic burden on the cellular metabolism which can largely be
attributed to the competition for precursors (amino acids, nucleotides),
energy (ATP, GTP) and reductive power (NAD(P)H) between cellular
processes related to growth and to recombinant protein production
(e.g., [111]). Interferencewithmetabolic ﬂuxes through targeted genet-
ic engineering (i.e., metabolic engineering) and supplementation of
limiting nutrients (i.e., medium and bioprocess optimization) are
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and elicit an augmentation of product yield and/or production ﬂux
(e.g., [110,112]). Insight in the altered cellular metabolism in recombi-
nant protein producing hosts can be obtained via metabolomics and
ﬂuxomics, or combinations thereof, and form the basis for proposing re-
mediation strategies. Microbial metabolomics includes the (qualitative
and/or quantitative) analysis of large sets of low-molecular weight
compounds in and around cells (e.g., [113]). In case metabolites to be
found are a priori known, one refers to targeted metabolomics, which
contrasts to untargeted (holistic) metabolomics. Analysis and quantiﬁ-
cation ofmetabolites typically rely on advanced hyphenated techniques
combining chromatographic separation techniques (e.g., GC, LC, CE)
and powerful detectors for identiﬁcation (e.g., MS, NMR, FT-IR). Analy-
sis of intracellular metabolites moreover demands for a ﬂow scheme of
rapid sampling, quenching, separation and extractionwhichneeds to be
carefully tested and optimized for each microorganism. Many reviews
address microbial metabolomics, focusing on the advanced analytical
tools exploited (e.g., [114–116]) and/or on thewhole process from sam-
pling and sample handling to quantiﬁcation (e.g., [117,118]). However,
no protocol is universal and protocols require validation and/or ﬁne-
tuning to the selected micro-organism. Kassama et al. [119], for exam-
ple, compared two extraction methods (freeze-thawing cycles and ul-
trasound) for S. lividans. The authors uncovered a metabolic shift in
S. lividans TK24 producing mTNF-α as compared to the wild type and
empty plasmid harbouring strain, using GC–MS andmulti-block princi-
ple component analysis. Concurrently, the metabolic footprint (i.e., ex-
tracellular metabolite proﬁles) of mTNF-α producing S. lividans TK24
also changes and exposes an imbalance between carbon and nitrogen
catabolism and biosynthetic ﬂuxes which also negatively impacts on
the growth rate [120]. Metabolomic changes in other recombinant pro-
tein producing hosts have been reported for, e.g., P. pastoris (e.g., [121])
and E. coli (e.g., [122]). Metabolic ﬁngerprints of P. pastoris under vari-
ous oxygen limiting conditions, with and without fragment antigen
binding (Fab) expression, show alterations in free amino acids pools
which aremost pronounced in response to changes in oxygen availabil-
ity but could also be associated with the production of (even small
amounts of) recombinant protein [121]. Carneiro et al. [122] corrobo-
rated the drainage of amino acid precursors and energy from growth
during IPTG-induced heterologous protein production in E. coli viamet-
abolic footprinting. A parallel investigation of a relA deletion mutant
highlighted the concurrent induction of a stress response triggered by
recombinant protein production. RelA integrates several environmental
triggers and coordinates the subsequent bacterial adaptation through
the synthesis of the alarmone ppGpp, which globally reprogrammes
transcription, translation, and replication (e.g., [123]). This importance
of stress response relaxation and avoidance towards improved protein
production is elaborated in the previous sections of this chapter.
To precisely pinpoint metabolic bottlenecks, it is mandatory to de-
termine ﬂuxes through metabolic pathways. Metabolic ﬂux analysis
(or ﬂuxomics) can be based on constrained stoichiometric calculations
(e.g., [124]) or on tracking 13C-labelling of substrates throughout in-
tracellular metabolites in so-called 13C-based metabolic ﬂux analysis
(e.g., [125]). Fluxomics studies on heterologous protein producing
streptomycetes have not been published thus far, but a number of stud-
ies for other host organisms have been reported (as reviewed in, e.g.,
[126–128]). Based on 13C-based metabolic ﬂux analysis, for example,
Driouch et al. [129] observed a signiﬁcant metabolic shift in Aspergillus
niger when heterologously producing the glycosylated enzyme
fructofuranosidase. The increased ﬂux through the cytosolic pentose
phosphate (PP) pathway and mitochondrial malic enzyme increased
the net NADPH generation, whereas the ﬂux through the energy-
generating TCA cycle was reduced. An in silico analysis of elementary
ﬂux modes and a correlation analysis identiﬁed several interesting
genes affecting the enzyme ﬂux. For example, a large positive correla-
tion was determined for zwf/gnd (catalyzing the conversion of
glucose-6-phosphate to 6-phosphogluconate) while a large negativecorrelationwas observed for pfk (phosphofructokinase) and/or citA (cit-
rate synthase). Although these genes have been identiﬁed as important
in a eukaryotic system, ﬂuxomics and metabolic engineering studies
have also pinpointed the relevance of these genes in prokaryotic sys-
tems and even in other biosynthesis processes such as natural product
secretion in streptomycetes. Borodina et al. [130] demonstrated that de-
letion of one of the pfk homologous genes in S. coelicolor increases the
PP pathway ﬂux and subsequently its natural antibiotic production.
Bushell et al. [131] observed increased actinorhodin biosynthesis in
S. coelicolor after deletion of one of the zwf genes, and the accompanying
ﬂux redistribution could be pictured through ﬂux balance analysis. In
S. roseosporus, Huang et al. [132] could increase daptomycin synthesis
by overexpression of zwf2. Clearly, these investigations illustrate the
importance of energy, reductive power, and precursor availability for
product synthesis. Removal of competitive carbon and nitrogen sinks
can therefore also positively affect heterologous product formation.
Gomez-Escribano and Bibb [133] reported increased heterologous anti-
biotic production in S. coelicolor after deletion of four endogenous anti-
biotic clusters. Systematic removal of non-essential genes in
S. avermitilismade a genome-minimized strain an interesting host for
the efﬁcient expression of heterologous gene clusters [134]. Other
works pinpointing metabolic bottlenecks particularly associated with
supply of building blocks, energy and/or reductive power include
Fürch et al. [135] (B. megaterium), Wittmann et al. [136] (E. coli), Ow
et al. [137] (E. coli) and Baumann et al. [138] (P. pastoris).
From these studies involving both eukaryotic and prokaryotic cells,
and Gram-positive as well as Gram-negative bacteria, it is clear that
ﬂuxes in the central metabolism are key parameters in heterologous
protein production.
Metabolome and ﬂuxome analysis can also be a guidance in up-
scaling and bioprocess development (e.g., [139]). Korneli et al. [140],
for example, performed a quantitative analysis of the intracellular
amino acids in B. megaterium grown in scale-down experiments
mimicking industrial conditions with intermittent substrate availability
(related to inadequate mixing). Protein production decreases and an
associated reduction of several intracellular free amino acid pools,
being key building blocks of the recombinant protein, could be
observed. Medium supplementation with these amino acids could
restore the protein yield to original lab-scale levels. Similarly, but now
based on an optimal medium design, Nowruzi et al. [141] optimized in-
terleukin 3 production in S. lividans 66 in a minimal medium through
addition of only three amino acids, i.e., aspartate, methionine and
phenylalanine.
5. Other Gram-positive hosts for secretion and possible applications
As already mentioned above, an important advantage of Gram-
positive bacteria is that they do not possess an outer membrane. As a
consequence, secreted proteins are immediately released into the cul-
ture medium, which promotes correct folding of the target proteins.
This immediate release facilitates downstream processing and is there-
fore economically more interesting, if yields are satisfactory. For this
reason various Gram-positive bacteria belonging to several genera are
being evaluated and further engineered as possible cell factories.
Below, a limited number of Gram-positive bacteria other than the
above-mentioned streptomycetes are discussed. For more details, the
interested reader is referred to reviews mentioned below.
Much attention has been paid to several Bacillus species, includ-
ing B. subtilis, Bacillus amyloliquefaciens, Bacillus licheniformis and
B. megaterium, because of their excellent secretion capacity (up to
25 g/l) and lack of toxicity. In addition, Bacillus spp. are used in in-
dustry for several applications.
B. subtilis is one of the most widely used bacteria for the production
of enzymes and special chemicals. Industrial applications include pro-
duction of amylase, proteases, hydrolases, inosine, ribosides, and amino
acids. B. subtilis has been shown also to produce a wide variety of
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crete high yields of recombinant proteins in Bacillus hosts were mixed.
Reasons therefore are a combination of the properties of the secretion
pathway, the Bacillus cell envelope, and degradation of the products
by the host proteases, i.e. the quality control proteases WprA, HtrA
and HtrB and feeding proteases NprB, AprE, Epr, Bpr, NprE, Mpr and
VprA [142]. Attempts to delete the quality control proteases led to slow-
ly growing cells prone to lysis, particularly under conditions of secretion
or temperature stress [143]. Several approaches have been tested to in-
crease the protein yield including overexpression of PsrA, an essential
protein that has sequence similarity to peptidyl–prolyl cis/trans isomer-
ases (PPIases) of the parvulin family [144]. Overexpression of PsrA led
to yield improvement of a limited number of proteins [143]. Another ap-
proach is to minimize the genome to optimize the production host. For
example, Morimoto et al. [145] reduced 20% of the B. subtilis genome by
rationally designed deletions, resulting in a strain with remarkably en-
hanced heterologous protein productivity, demonstrating the feasibility
of applying minimized genomes to construct high yielding production
strains. As discussed by Liu et al. [146], thanks to the availability of
new tools for controlling metabolic pathways, systems-level research
methodologies, and in silico-aided strategies more accurate and well-
balanced approaches are becoming available to achieve the expected
cellular properties and to shed light on themetabolic control, the stress
provoked by hyper-secretion and possible ways for remediation. Sys-
temsmetabolic engineeringwill certainly help tomanipulate organisms
to maximize production as illustrated for B. megaterium [147].
Among the high-GC bacteria, besides S. lividans, other actinomy-
cetes have also been successfully tested as host cells for heterologous
protein production. These includeMycobacterium smegmatis, Rhodococcus
erythropolis and Corynebacterium glutamicum. It is somewhat surprising
that these diderm-mycolate bacteria can efﬁciently secrete (heterolo-
gous) proteins, notwithstanding the presence of an extra outer layer
consisting mainly of mycolic acid.M. smegmatis, a non-pathogenic close
relative ofM. tuberculosis, is widely used for the efﬁcient expression and
puriﬁcation of M. tuberculosis proteins [148,149]. R. erythropolis has a
broad metabolic diversity and a number of unique enzymatic activities
of industrial interest. Several efﬁcient expression vectors have been con-
structed [150], allowing the production of heterologous proteins. Since
Rhodococcus spp. can grow at temperatures ranging between 4 °C and
35 °C, protein expression at 4 °C was possible, a temperature often
more preferable for the production of recombinant proteins [151]. At
this low temperature some mouse proteins that could not be expressed
in E. coli could be expressed in Rhodococcus at 4 °C [150].
The genus Corynebacterium includes several human and animal path-
ogens, but also many non-pathogenic species such as C. glutamicum.
The latter is well-known as an industrial strain for the production
of sodium glutamate and L-lysine. C. glutamicum has several attrac-
tive features, making it a potentially interesting host for the produc-
tion of heterologous proteins at an industrial scale: C. glutamicum
secretes signiﬁcantly less endogenous proteins and no proteases in
the culture ﬁltrate are detected, although a proteome analysis revealed
the presence of more than 40 proteins in the culture supernatant [152].
Moreover, a total of 108 candidate signal sequences (98 Sec-type and 10
Tat-type) that could secrete heterologous α-amylase in C. glutamicum
were identiﬁed [20]. The lack of detectable extracellular proteolytic en-
zyme activity [153] guarantees the stability and productivity of heterol-
ogous proteins of which several were shown to be efﬁciently secreted.
Examples are amylase, nuclease, protease, transglutaminase (TGase),
subtilisin-like serine protease, epidermal growth factor, green ﬂuores-
cent protein and Chryseobacterium proteolyticum protein-glutaminase
using either the Sec or Tat pathway [20]. Yield optimization has been
attemptedusing different signal peptides (Tat or Sec, homologous, heter-
ologous), and overexpression of the Tat components [95]. Based on 13C
metabolic ﬂux analysis it was found that TGase yield of a recombinant
strain decreased and the ﬂux from glycolysis to the TCA cycle increased
in a time-dependent manner. It was supposed that the increase in theﬂux to the TCA cycle might result in an increase in the NADH/NAD+
ratio, and that as a result, the speciﬁc glucose uptake rate decreases in
the stationary phase because of the increased ﬂux of the TCA cycle. It
was thought that it was one of the reasons for the decrease in TGase
yield. To decrease the NADH/NAD+ ratio, lactate production was en-
hanced by increasing the pH level in the culture, which successfully in-
creased TGase yield [154].
In contrast to the bacteria described above, which are aimed for the
industrial production of (heterologous) proteins, a number of other spe-
cies such as food grade lactic acid bacteria (LAB), Biﬁdobacterium and
Clostridium are tested for the in vivo delivery of therapeutic proteins.
Interesting examples are lactococci (e.g., Lactococcus lactis) and
lactobacilli (e.g., Lactobacillus fermentum, Lactobacillus casei, Lactoba-
cillus acidophilus, Lactobacillus plantarum) (for an overview, see
[155]). These strains were designed to be used as safe mucosal deliv-
ery vectors formolecules of health interest based on the local synthesis
and delivery of therapeutic proteins. E.g., L. lactiswas genetically modi-
ﬁed to secrete interleukin 10. For safety reasons, the thymidylate syn-
thase gene thyA of L. lactis was replaced by a synthetic human IL10
cDNA. This strain deprived of thymidine or thymine was less viable, es-
sentially preventing its accumulation in the environment [156]. They
further demonstrated that intragastric administration of the IL-10 se-
creting L. lactis caused a signiﬁcant reduction in colitis in mousemodels
[157]. In the meantime, many antigens and/or cytokines have been
successfully expressed in LAB, and mucosal administration of these ge-
netically engineered LAB has been shown to elicit both systemic and
mucosal immunity. Furthermore, orally administered L. lactis secreting
an anti-TNF nanobody demonstrated efﬁcacy in chronic colitis in a
mice model [158]. Human clinical trials are now an important next
step to conclude on the beneﬁts of these modiﬁed lactic acid bacteria
in human health.
Clostridium and Biﬁdobacterium are used in bacterial-directed
antitumour therapy. Several species belonging to these genera have
been demonstrated in rodent models to localize to and replicate in tu-
mour tissue, when administered intratumourally or intravenously. In
the case of Biﬁdobacterium breve, a native, harmless resident of the
human gut, orally administered bacteria colonized both primary tu-
mours and smaller secondarymetastatic tumours [159]. The underlying
reason for the tumour speciﬁcity is that these strictly anaerobic bacteria
speciﬁcally target the hypoxic/necrotic regions of the tumours as they
will only home and replicate under anaerobic conditions, a situation
which occurs in the body only in these regions. From non-malignant/
healthy tissues they are therefore quickly cleared. Hypoxia is caused
by rapidly growing tumours with insufﬁcient blood supply, and is a
well-established feature of solid tumours. Moreover, in the latter re-
gions the effectiveness of conventional therapies is dramatically limited.
The administered bacteria colonizing the hypoxic/anaerobic region of
the tumour cause the antitumour effect by several mechanisms. Due
to the proteolytic and lipolytic action several clostridial strains have
been shown to be capable of speciﬁcally destroyingmost tumour tissues
after spores were i.v. injected into tumour models [160] and/or human
patients [161], and increased an immunological antitumour response.
To augment the efﬁcacy of these tumour targeting bacteria, they were
harmed to express anticancer therapeutic genes in these hosts and,
where applicable, to secrete the encoded proteins in the tumour
micro-environment. To do so, the proteins of interest such as TNFα, in-
terleukin 2, the prodrug-converting enzymes cytosine deaminase and
thymidine kinase, and others [162] were expressed as preproteins con-
taining the signal peptide of efﬁciently secreted homologous proteins
such as clostripain [163]. In the framework of developing an ideal anti-
cancer therapy, which selectively eradicate tumours, while minimizing
side effects to normal tissue, these bacterial-directed anticancer therapy
looks very promising, either alone or in combination with chemo- or
radiotherapy, if enough therapeutic protein can be delivered at the tu-
mour site. More insight in the secretion pathways of the relevant bacte-
ria might therefore be very helpful.
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For the production of heterologous proteins, several cell factories
have been developed and applied for several purposes, and each with
their own advantages, but also with the possible drawbacks. No doubt,
a major advantage of Gram-positive bacteria is that target proteins,
when equipped with the necessary secretion tag, can be secreted out-
side of the cell enabling correct folding and accompanying functionality
as such facilitating downstream processing. As yield of secretion is very
important to make the process economically viable, several attempts to
improve the secretion process have consequently been reported. As il-
lustrated in this review primarily for S. lividans, but also tested and ap-
plicable for other Gram-positive bacteria, selection or adjustments of
the signal peptide, selection of the Sec or Tat secretion pathway, overex-
pression of genes encoding, for example, signal peptidases or, where
relevant, proteins of the Tat pathway, often have led to increased yields.
Results undoubtedly showed that S. lividans can serve as an efﬁcient
production platform for a number of proteins. Which proteins can be
produced successfully in a certain host, and which route needs to be
followed to obtain an economically valuable secretory production sys-
tem cannot yet be predicted, but has to be tested. Most often the
approaches followed were typically exploited for a speciﬁc (set of) pro-
tein(s). The combination of several approaches has hardly been tested.
Furthermore, a systems biology approach, addressed by using multi-
omics tools (transcriptomics, metabolomics, ﬂuxomics) to investigate
the various system levels (genes, metabolites, ﬂuxes) in a cell and to
correlate these observationswith themetabolic and regulatory burdens
experienced during heterologous protein production, is still in its infan-
cy, although the ﬁrst preliminary results showed already the successes
of this integrated approach. Relaxation of stress as well as interference
with the metabolism has already been shown to increase heterologous
protein yields in S. lividans. Clearly, these state-of-the-art technologies
including multi-omics strategies combined with bioinformatics and so-
phisticated techniques and equipment can further help to create cell
factories with improved properties. Finally, one should not forget that
besides yield improvement based on amolecular adaptation, the impor-
tance of fermentation conditions cannot be overlooked.Acknowledgement
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